Some thoughts on the mechanism of cellular trapping of Cu(II)-ATSM.

作者: Jason L.J. Dearling , Alan B. Packard

DOI: 10.1016/J.NUCMEDBIO.2009.11.004

关键词:

摘要: Cu(II)-ATSM continues to be investigated, both in the laboratory and clinic, as a tumor hypoxia imaging agent. However, meaningful interpretation of these images requires more complete understanding mechanism by which tracer is trapped within cell. simple molecule its biochemical interaction with cells similarly simple, mainly based upon redox chemistry. Here we suggest that trapping biphasic. The first phase reduction/oxidation cycle involving thiols molecular oxygen. This can followed proteins mitochondria leading permanent retention tracer. uptake complicated this second step because changes cell resulting from hypoxia, such an increase nicotinamide adenine dinucleotide (NADH) state differences cellular biochemistry proteomes. These may lead extent (64)Cu different types. For example, copper might increased lower pH due stability metal bis(thiosemicarbazones) under acidic conditions. Reaction rates reductants also vary pH, differs between organelles. reach full potential, characterization types required.

参考文章(27)
Philip J. Blower, Jason S. Lewis, Jamal Zweit, Copper radionuclides and radiopharmaceuticals in nuclear medicine Nuclear Medicine and Biology. ,vol. 23, pp. 957- 980 ,(1996) , 10.1016/S0969-8051(96)00130-8
Paul Burgman, Joseph A. O'Donoghue, Jason S. Lewis, Michael J. Welch, John L. Humm, C. Clifton Ling, Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM. Nuclear Medicine and Biology. ,vol. 32, pp. 623- 630 ,(2005) , 10.1016/J.NUCMEDBIO.2005.05.003
Christine H. Chan-Stier, Daniel Minkel, David H. Petering, Reactions of Bis(thiosemicarbazonato) Copper(II) complexes with tumor cells and mitochondria Bioinorganic Chemistry. ,vol. 6, pp. 203- 217 ,(1976) , 10.1016/S0006-3061(00)80227-6
James R. Ballinger, Imaging hypoxia in tumors Seminars in Nuclear Medicine. ,vol. 31, pp. 321- 329 ,(2001) , 10.1053/SNUC.2001.26191
Yasuhisa Fujibayashi, Hideyuki Taniuchi, Kouichi Wada, Yoshiharu Yonekura, Junji Konishi, Akira Yokoyama, Differential mechanism of retention of Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imaging. Annals of Nuclear Medicine. ,vol. 9, pp. 1- 5 ,(1995) , 10.1007/BF03164977
Joseph A. O’Donoghue, Pat Zanzonico, Andrei Pugachev, Bixiu Wen, Peter Smith-Jones, Shangde Cai, Eva Burnazi, Ronald D. Finn, Paul Burgman, Shutian Ruan, Jason S. Lewis, Michael J. Welch, C. Clifton Ling, John L. Humm, Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models International Journal of Radiation Oncology Biology Physics. ,vol. 61, pp. 1493- 1502 ,(2005) , 10.1016/J.IJROBP.2004.12.057
Thies Schroeder, Hong Yuan, Benjamin L. Viglianti, Cathryn Peltz, Shubha Asopa, Zeljko Vujaskovic, Mark W. Dewhirst, Spatial Heterogeneity and Oxygen Dependence of Glucose Consumption in R3230Ac and Fibrosarcomas of the Fischer 344 Rat Cancer Research. ,vol. 65, pp. 5163- 5171 ,(2005) , 10.1158/0008-5472.CAN-04-3900
Peter Vaupel, Arnulf Mayer, Hypoxia in cancer: significance and impact on clinical outcome Cancer and Metastasis Reviews. ,vol. 26, pp. 225- 239 ,(2007) , 10.1007/S10555-007-9055-1
Su-Ju Lin, Leonard Guarente, Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease Current Opinion in Cell Biology. ,vol. 15, pp. 241- 246 ,(2003) , 10.1016/S0955-0674(03)00006-1